Allison Stange lost 40 pounds since starting Zepbound in April 2024, improving both her blood pressure and sleep apnea. Now ...

US pharma major Eli Lilly (NYSE: LLY) yesterday announced executive leadership transitions that will further enhance the ...

Medicare recipients suffering from obesity must pay out of pocket for weight loss drugs like Wecovy and Zepbound.

The current volatile situation shouldn't preclude investors from buying stocks. Eli Lilly, Vertex, Meta Platforms, and ...

Shares in Eli Lilly have weakened ... retained coverage of Zepbound's arch rival Wegovy (semaglutide), sold by Novo Nordisk, after negotiating a price cut with the company, along with Novo ...

Novo Nordisk's stock has plummeted over 60%, while also arguably losing market share to Eli Lilly. Click here to find out why ...

Founded in 1963 by Jean Nidetch, WeightWatchers began as a weekly weight-loss support group with just 400 attendees. It quickly grew into a global phenomenon, attracting millions of members worldwide ...

WeightWatchers, officially rebranded as WW International ( NASDAQ: WW ), has blamed its financial woes on the GLP-1 drug wave ...

Why Trump's vision to bring home all U.S. manufacturing is 'almost impossible' President Donald Trump's 'Made in America' push is prompting some U.S. companies to expand domestic production ...